{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T09:15:40Z","timestamp":1783329340757,"version":"3.54.6"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T00:00:00Z","timestamp":1776902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"publisher","award":["1404-3-103-35313"],"award-info":[{"award-number":["1404-3-103-35313"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Oncology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.omton.2026.201218","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T16:16:13Z","timestamp":1777306573000},"page":"201218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV\/HCV-associated hepatocellular carcinoma"],"prefix":"10.1016","volume":"34","author":[{"given":"Fahimeh","family":"Safarnezhad Tameshkel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niloufar","family":"Sadat Kalaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Karimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Hossein","family":"Razizadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abed El Hasan","family":"Haidar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Amiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammadreza","family":"Zaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Nikkhah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1364-5743","authenticated-orcid":false,"given":"Mohammad Hadi","family":"Karbalaie Niya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omton.2026.201218_bib1","first-page":"1","article-title":"Hepatocellular carcinoma (HCC): Epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv. Cancer Res."},{"key":"10.1016\/j.omton.2026.201218_bib2","doi-asserted-by":"crossref","DOI":"10.1097\/CLD.0000000000000143","article-title":"Management of HBV reactivation: Challenges and opportunities","volume":"23","author":"Mezzacappa","year":"2024","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.omton.2026.201218_bib3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1038\/s41590-024-01928-4","article-title":"Attenuated effector T cells are linked to control of chronic HBV infection","volume":"25","author":"Heim","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.omton.2026.201218_bib4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3390\/cancers15020533","article-title":"Hepatitis virus and hepatocellular carcinoma: recent advances","volume":"15","author":"Shen","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.omton.2026.201218_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2026.201218_bib6","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omton.2026.201218_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","article-title":"UALCAN: An update to the integrated cancer data analysis platform","volume":"25","author":"Chandrashekar","year":"2022","journal-title":"Neoplasia"},{"key":"10.1016\/j.omton.2026.201218_bib8","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.omton.2026.201218_bib9","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.7150\/jca.39972","article-title":"Glypican-3: a new target for diagnosis and treatment of hepatocellular carcinoma","volume":"11","author":"Guo","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.omton.2026.201218_bib10","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.7150\/jca.52187","article-title":"Centromere protein F (CENPF) serves as a potential prognostic biomarker and target for human hepatocellular carcinoma","volume":"12","author":"Huang","year":"2021","journal-title":"J. Cancer"},{"key":"10.1016\/j.omton.2026.201218_bib11","doi-asserted-by":"crossref","first-page":"847","DOI":"10.21037\/tcr-23-1474","article-title":"Upregulation of RACGAP1 is correlated with poor prognosis and immune infiltration in hepatocellular carcinoma","volume":"13","author":"Zhou","year":"2024","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.omton.2026.201218_bib12","article-title":"Experts' Cognition-Driven Ensemble Deep Learning for External Validation of Predicting Pathological Complete Response to Neoadjuvant Chemotherapy from Histological Images in Breast Cancer","author":"Yang","year":"2023","journal-title":"arXiv"},{"key":"10.1016\/j.omton.2026.201218_bib13","doi-asserted-by":"crossref","first-page":"112","DOI":"10.47852\/bonviewMEDIN42022652","article-title":"Exploring Disrupted Gene Networks in Human 22q11. 2 Microdeletion","volume":"1","author":"de Oliveira Alves","year":"2024","journal-title":"Medinformatics"},{"key":"10.1016\/j.omton.2026.201218_bib14","doi-asserted-by":"crossref","first-page":"211","DOI":"10.47852\/bonviewMEDIN42023658","article-title":"ACO-Guided Genetic Analysis: Exploring the Role of Genes in Alzheimer's Disease","volume":"1","author":"Zhu","year":"2024","journal-title":"Medinformatics"},{"key":"10.1016\/j.omton.2026.201218_bib15","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1053\/j.gastro.2017.06.007","article-title":"Identification of an immune-specific class of hepatocellular carcinoma, based on molecular features","volume":"153","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.omton.2026.201218_bib16","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.738841","article-title":"Expression levels of three key genes CCNB1, CDC20, and CENPF in HCC are associated with antitumor immunity","volume":"11","author":"Si","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omton.2026.201218_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.655697","article-title":"Hepatocellular Carcinoma Immune Landscape and the Potential of Immunotherapies","volume":"12","author":"Giraud","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.omton.2026.201218_bib18","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3892\/ol.2020.12095","article-title":"High expression of TOP2A in hepatocellular carcinoma is associated with disease progression and poor prognosis","volume":"20","author":"Cai","year":"2020","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.omton.2026.201218_bib19","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.3390\/medicina58121803","article-title":"Comparative RNA-sequencing analysis reveals high complexity and heterogeneity of transcriptomic and immune profiles in hepatocellular carcinoma tumors of viral (HBV, HCV) and non-viral etiology","volume":"58","author":"Paslaru","year":"2022","journal-title":"Medicina"},{"key":"10.1016\/j.omton.2026.201218_bib20","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1038\/s41417-021-00404-7","article-title":"Centromere protein F promotes progression of hepatocellular carcinoma through ERK and cell cycle-associated pathways","volume":"29","author":"Chen","year":"2022","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.omton.2026.201218_bib21","doi-asserted-by":"crossref","first-page":"4814","DOI":"10.1158\/1078-0432.CCR-07-5262","article-title":"ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma","volume":"14","author":"Lin","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201218_bib22","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1002\/2211-5463.13278","article-title":"ASPM promotes hepatocellular carcinoma progression by activating Wnt\/\u03b2-catenin signaling through antagonizing autophagy-mediated Dvl2 degradation","volume":"11","author":"Zhang","year":"2021","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.omton.2026.201218_bib23","doi-asserted-by":"crossref","first-page":"7836","DOI":"10.3390\/ijms26167836","article-title":"Immunological Landscape and Molecular Therapeutic Targets of the Tumor Microenvironment in Hepatocellular Carcinoma","volume":"26","author":"Zarlashat","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omton.2026.201218_bib24","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.1158\/1078-0432.CCR-18-3040","article-title":"Activated and exhausted MAIT cells foster disease progression and indicate poor outcome in hepatocellular carcinoma","volume":"25","author":"Duan","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.omton.2026.201218_bib25","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jhep.2021.08.029","article-title":"Intratumoral stem-like CCR4+ regulatory T cells orchestrate the immunosuppressive microenvironment in HCC associated with hepatitis B","volume":"76","author":"Gao","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.omton.2026.201218_bib26","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1186\/s12967-025-06869-6","article-title":"Single-cell RNA sequencing reveals a B cell-related immunosuppressive landscape and a potential suppressor in hepatocellular carcinoma","volume":"23","author":"Hou","year":"2025","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.omton.2026.201218_bib27","article-title":"Single cell-RNA sequencing reveal TOP2A as a key driver of hepatocellular carcinoma progression","volume":"15","author":"Xie","year":"2025","journal-title":"Sci. Rep."}],"container-title":["Molecular Therapy Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2950329926000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T08:23:09Z","timestamp":1783326189000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2950329926000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2950329926000949"],"URL":"https:\/\/doi.org\/10.1016\/j.omton.2026.201218","relation":{},"ISSN":["2950-3299"],"issn-type":[{"value":"2950-3299","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An integrative transcriptomic analysis for prognosis and tumor microenvironment in HBV\/HCV-associated hepatocellular carcinoma","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omton.2026.201218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of The American Society of Gene and Cell Therapy.","name":"copyright","label":"Copyright"}],"article-number":"201218"}}